ENDRA Life Sciences (NDRA) just unveiled an announcement.
ENDRA Life Sciences Inc. has announced that they’ve received additional time from a Nasdaq Hearing Panel to meet the minimum bid price requirement needed to stay listed on the Nasdaq Capital Market. The company, with 17,280,655 shares of common stock outstanding as of August 28, 2024, is working towards compliance to maintain its listing status.
See more insights into NDRA stock on TipRanks’ Stock Analysis page.
